Evidence map›Paper›PMID 29607405›Full record

ArticleAdvanced biosystems2017

Scalable Production and Cryostorage of Organoids Using Core-Shell Decoupled Hydrogel Capsules.

Yen-Chun Lu, Dah-Jiun Fu, Duo An, Alan Chiu, Robert Schwartz, Alexander Yu Nikitin, Minglin Ma

Open access · greenAbstract read
In one paragraph

Article in Advanced biosystems, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Towards organoid culture without Matrigel.Communications biology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Vitamin C and BJournal of biomedical materials research. Part A · 2019
    Article
  19. Review
  20. Towards Multi-Organoid Systems for Drug Screening Applications.Bioengineering (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yen-Chun LuDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
Dah-Jiun FuDepartment of Biomedical Science, Cornell University, Ithaca, NY 14853, USA.
Duo AnDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
Alan ChiuDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
Robert SchwartzWeill Medical College of Cornell University, 445 E 69th St, New York, NY 10065, USA.
Alexander Yu NikitinDepartment of Biomedical Science, Cornell University, Ithaca, NY 14853, USA.
Minglin MaDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
Cornell University · US

Funding

Origins of Ovarian CarcinomaR01CA182413 · NCI · CORNELL UNIVERSITY · PI NIKITIN, ALEXANDER Y. · 2015 to 2019
$1.8M
Neuroendocrine mechanisms of prostate cancer progressionR01CA197160 · NCI · CORNELL UNIVERSITY · PI NIKITIN, ALEXANDER Y. · 2015 to 2020
$1.8M
Organogenesis in microcapsules: developing an efficient and scalable organoid culture platformR03EB020910 · NIBIB · CORNELL UNIVERSITY · PI MA, MINGLIN · 2015 to 2016
$144k
NCI NIH HHS R01 CA182413NCI NIH HHS R01 CA197160NIBIB NIH HHS R03 EB020910
6 · The paper itself

Abstract

Organoids, organ-mimicking multicellular structures derived from pluripotent stem cells or organ progenitors, have recently emerged as an important system for both studies of stem cell biology and development of potential therapeutics; however, a large-scale culture of organoids and cryopreservation for whole organoids, a prerequisite for their industrial and clinical applications, has remained a challenge. Current organoid culture systems relying on embedding the stem or progenitor cells in bulk extracellular matrix (ECM) hydrogels (e.g., Matrigel™) have limited surface area for mass transfer and are not suitable for large-scale productions. Here, we demonstrate a capsule-based, scalable organoid production and cryopreservation platform. The capsules have a core-shell structure where the core consists of Matrigel™ that supports the growth of organoids, and the alginate shell form robust spherical capsules, enabling suspension culture in stirred bioreactors. Compared with conventional, bulk ECM hydrogels, the capsules, which could be produced continuously by a two-fluidic electrostatic co-spraying method, provided better mass transfer through both diffusion and convection. The core-shell structure of the capsules also leads to better cell recovery after cryopreservation of organoids probably through prevention of intracellular ice formation.

Indexed as

biomanufacturingcryopreservationencapsulationorganoid

Identifiers

PMID29607405
PMCPMC5870136
OpenAlexW2770441697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.